Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases

US8518918B2 · kind B2 · utility

Assignee

• MEDA PHARMA GMBH & CO. KG · DE

Inventors

• Joachim Maus · Mühlheim, DE
• Kastrup Horst · Munster, DE
• Istvan Szelenyi · Arnstorf, DE
• Peter Jurgen Cnota · Bad Homburg vor der Höhe, DE
• Bauhofer Artur · Marburg, DE

Key dates

• Filing date: Sep 23, 2011
• Grant date: Aug 27, 2013
• Expiry date: Sep 23, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/008
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel combinations based on anticholinergics, β2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases.